// App-Quantinova.ai

715 : Phosphatidylserine Exposing-Blood Cells and Microparticles Induce Procoagulant Activity in Non-Valvular Atrial Fibrillation

Researchers

Presenter

  • Lixiu Wang

Principal Investigators

  • Lu Zhao

  • Yan Zhang

  • Zhipeng Yao

  • Tao Li

  • Muhua Cao

  • Ruishuang Ma

  • Xiaoming Wu

  • Junjie Kou

  • Jialan Shi

  • Yayan Bi

Medical Centers

  • Departments of Surgery, VA Boston Healthcare System, Brigham and Women's Hospital, Boston, MA

  • Department of Hematology, The First Affiliated Hospital, Harbin Medical University, Harbin, China

  • Department of Hematology, The First Affiliated Hospital, Harbin Medical University, Harbin, China

  • Department of Gastroenterology, The Second Hospital of Hebei Medical University, Shijiazhuang, China

Locations

  • United States

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Non-valvular atrial fibrillation

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Phosphatidylserine

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim